Drug Approvals
🌏 NMPA Page 2NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 13–24 of 97 articles
Regulatory Round-Up: Key Drug Approvals on May 18, 2026
FDA · 5 min
Dr. Yuki TanakaOptical Coherence Tomography Gains Regulatory Traction in Pharma Filings
FDA · 6 min
Dr. Yuki TanakaDatroway Approved: A New Hope for Metastatic TNBC Patients
FDA · metastatic TNBC · 5 min
Dr. Yuki TanakaKelun-Biotech Secures New Drug Approval for SKB118: Investor and BD Guide
FDA · oncology · 5 min
Dr. Yuki TanakaAbbVie Secures FDA Approval for ImmunoGen's Elahere
FDA · rare blood cancers · 6 min
Dr. Yuki TanakaPREMIA and Lind Launch Lind Asia to Revolutionize Clinical Trials with AI
FDA · 5 min
Dr. Yuki TanakaPMDA Approves New Pharmaceuticals and Medical Devices: What's New
PMDA · 4 min
Dr. Yuki TanakaShionogi's Xocova Gains FDA Clearance for COVID-19 Post-Exposure Prevention
FDA · COVID-19 · 7 min
Dr. Sarah MitchellGlobal Regulatory Agencies Update Real-World Evidence Guidance for Decision-Making
7 min
Dr. Yuki TanakaChina's Ascendancy in Oncology Research Alarms European Oncologists, Threatening Europe's Competitive Edge
oncology · 9 min
Dr. Yuki TanakaASCO 2026: Asian Oncology Innovation Takes Center Stage, Driving Global Clinical Trial Advancements
oncology · 6 min
Dr. Yuki TanakaCDER Leadership Changes: Navigating the Impact on Pharmaceutical Strategy
FDA · 11 min
Dr. Yuki Tanaka